跳至主要内容
临床试验/NCT00721994
NCT00721994已完成不适用

Cormet Resurfacing Hip System Post PMA Approval Study (PMA #P050016)Pre-market (IDE) Study Group 10 Year Follow-Up With Metal Ion and Renal Function Data Collection Clinical Investigation Plan

Corin5 个研究点 分布在 1 个国家目标入组 231 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Corin
入组人数
231
试验地点
5
主要终点
to monitor the clinical performance of the Cormet implant system for a period of up to 10 years postoperative in order to confirm that there are no unexpected reductions in device performance following PMA approval

研究概览

简要总结

primary endpoint of this Study is maintenance of "at least good clinical status" for a period of 10 years following initial implantation among Cormet procedures enrolled inthe pre-market IDE.

详细描述

Maintaining "at least good clinical status" will be determined based upon the composite clinical success (CCS) criterion which includes no revision, removal, or replacement of any device component and a Harris Hip Total score of greater or equal to 80 points.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • subjects enrolled in the Cormet IDE study at the 5 identified clinical sites
  • Individuals who agree to participate in the study by signing the informed patient consent form

排除标准

  • 未提供

结局指标

主要结局

to monitor the clinical performance of the Cormet implant system for a period of up to 10 years postoperative in order to confirm that there are no unexpected reductions in device performance following PMA approval

时间窗: 10 years

次要结局

  • device survival(10 years)
  • device related adverse events(10 years)
  • radiographic evaluation including radiolucencies, component migration, and femoral subsidence and tilt(10 years)
  • Harris Hip Score components including total score, pain, function and range of motion(10 years)
  • whole blood trace metals and renal function(10 years)

研究者

发起方
Corin
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验